Vivos Inc. (RDGL)
OTCMKTS · Delayed Price · Currency is USD
0.1201
+0.0026 (2.21%)
Aug 1, 2025, 3:56 PM EDT

Vivos Company Description

Vivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States.

The company develops an yttrium-90 based precision radionuclide therapy device; RadioGel, which is an injectable particle-gel for Precision Radionuclide Therapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals.

It is also developing a universal laboratory cooling device; hydrogel; and other products under the Alpha-Gel, Beta-Gel, Gamma-Gel, and Precisiongel names.

The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc. in December 2017.

Vivos Inc. was incorporated in 1994 and is headquartered in Kennewick, Washington.

Vivos Inc.
CountryUnited States
Founded1994
IndustryMedical Devices
SectorHealthcare
Employees1
CEOMichael Korenko

Contact Details

Address:
1030 N Center Parkway
Kennewick, Delaware 99352
United States
Phone509 222 2222
Websiteradiogel.com

Stock Details

Ticker SymbolRDGL
ExchangeOTCMKTS
Fiscal YearJanuary - December
Reporting CurrencyUSD
ISIN NumberUS92858K2042
SIC Code2835

Key Executives

NamePosition
Dr. Michael K. Korenko Ph.D.Chief Executive Officer, President and Director
Dr. Carlton M. Cadwell D.D.S.Independent Chairman and Secretary
Michael H. Pollack CPAChief Financial Officer
Dr. David J. Swanberg M.S., P.E.Chief Technical Manager
LeeAnna D. BinderSocial Media and Marketing Manager